Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Operating Expenses: 2020-2021

Historic Operating Expenses for Cardiol Therapeutics (CRDL) over the last 2 years, with Dec 2021 value amounting to $30.9 million.

  • Cardiol Therapeutics' Operating Expenses rose 25.54% to $10.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $36.7 million, marking a year-over-year change of. This contributed to the annual value of $30.9 million for FY2021, which is 100.17% up from last year.
  • Latest data reveals that Cardiol Therapeutics reported Operating Expenses of $30.9 million as of FY2021, which was up 100.17% from $15.4 million recorded in FY2020.
  • In the past 5 years, Cardiol Therapeutics' Operating Expenses ranged from a high of $30.9 million in FY2021 and a low of $15.4 million during FY2020.
  • Its 2-year average for Operating Expenses is $23.2 million, with a median of $23.2 million in 2021.
  • Data for Cardiol Therapeutics' Operating Expenses shows a peak YoY soared of 100.17% (in 2021) over the last 5 years.
  • Over the past 2 years, Cardiol Therapeutics' Operating Expenses (Yearly) stood at $15.4 million in 2020, then surged by 100.17% to $30.9 million in 2021.